Trusted by 100,000+ women across the US, UK & Canada. One purchase. Unlimited attempts.
FERTILITY HEALTH

GLP-1 Medications and Fertility: What to Know Before You Start Trying to Conceive

Published April 16, 2026 · 10 min read

MakeAmom Editorial Team By the MakeAmom Editorial Team
Woman holding injectable medication pen next to a positive pregnancy test

GLP-1 receptor agonists — the class of medications that includes semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Victoza, Saxenda) — have transformed weight management and type 2 diabetes care. Millions of women are now taking them. But what happens when one of those women wants to get pregnant?

If you're on a GLP-1 medication and trying to conceive — or thinking about it — you are not alone, and your questions are the right ones to be asking. The intersection of GLP-1 drugs and fertility is genuinely complicated, with some surprising upsides and some real risks that require careful timing. Here's what the current evidence actually says.

How GLP-1 Medications Affect Female Fertility

The relationship between GLP-1 receptor agonists and fertility is not straightforward — it cuts both ways depending on what's driving your fertility challenges in the first place.

The Upside: Weight Loss Can Restore Ovulation

For women with PCOS, obesity-related anovulation, or irregular cycles linked to metabolic dysfunction, GLP-1 medications can be genuinely fertility-enhancing — before pregnancy. Here's why: excess body fat drives elevated insulin and androgen levels, which disrupt the hormonal signaling required for regular ovulation. When a GLP-1 medication produces meaningful weight loss and improves insulin sensitivity, the hormonal environment often normalizes and ovulation resumes.

A 2023 study published in Reproductive BioMedicine Online found that women with PCOS who lost at least 5–10% of body weight through medical management, including GLP-1 therapy, showed significantly improved ovulation rates and menstrual regularity compared to those who did not. The mechanism is direct: lower insulin levels reduce ovarian androgen production, allowing follicle-stimulating hormone (FSH) to do its job.

This is why some OB/GYNs and reproductive endocrinologists have used semaglutide and liraglutide intentionally to help women with PCOS restore ovulatory cycles ahead of a planned pregnancy attempt. But there's a critical caveat that comes with this benefit.

The Risk: Unexpected Pregnancies During GLP-1 Treatment

Because GLP-1 medications can restore ovulation in women who were previously anovulatory, they can trigger pregnancies that were not anticipated — including in women who thought they were infertile. There are documented cases of women becoming pregnant unexpectedly while on semaglutide after years of irregular or absent periods.

If you are sexually active with a sperm-producing partner and are taking a GLP-1 medication, you need effective contraception unless you are actively trying to conceive — specifically because the medications themselves are not safe during pregnancy (more on this below).

GLP-1 Medications and Oral Contraceptive Absorption

There is an additional layer of complexity for women on oral contraceptives. GLP-1 medications slow gastric emptying — food and pills move through your stomach more slowly. This can reduce the absorption of oral contraceptives, potentially lowering their efficacy. The FDA prescribing information for semaglutide notes this interaction and recommends that women on oral contraceptives use a barrier method as a backup for the first four weeks of GLP-1 treatment and after any dose increase.

Are GLP-1 Medications Safe During Pregnancy?

No. Current guidelines are unambiguous: GLP-1 receptor agonists should be discontinued before conception and are contraindicated during pregnancy.

Animal studies with semaglutide have shown dose-dependent embryo-fetal toxicity, including structural abnormalities, at exposures achievable in humans. While human pregnancy data is limited — most pregnancies have been accidental exposures — the safety signal from preclinical studies is concerning enough that every major guideline recommends stopping before trying to conceive.

The Endocrine Society and the American College of Obstetricians and Gynecologists (ACOG) both recommend discontinuing GLP-1 medications at least two months before attempting conception. Some reproductive endocrinologists advise stopping even earlier — up to three to four months — to allow the drug to fully clear your system, particularly for long-acting formulations like once-weekly semaglutide.

How Long Does Semaglutide Stay in Your Body?

Semaglutide has a half-life of approximately one week. This means it takes roughly five to seven half-lives — five to seven weeks — for the drug to be largely cleared from your system. However, because the drug distributes into tissues and has active effects beyond serum levels, the recommended washout period before pregnancy attempts is typically two months minimum, with many specialists recommending three to four months to be cautious.

Tirzepatide has a similar half-life and carries the same precautions. Liraglutide, a daily injectable, clears faster (half-life ~13 hours), so the washout window is shorter — but the same principle of discontinuing before conception applies.

GLP-1 Medications, PCOS, and Timing Your TTC Journey

If you have PCOS and are using a GLP-1 medication to lose weight and restore ovulatory cycles before trying to conceive, here is a practical framework for thinking about timing:

  1. Use GLP-1 therapy to reach a healthier weight and restore regular cycles. This phase can take 6–18 months. Work with your prescribing physician and OB/GYN together during this period.
  2. Once your cycles are regular and you're approaching your target weight, plan your transition. Decide together with your doctor when to discontinue the GLP-1 medication. Build in the recommended 2–4 month washout period before your first insemination attempt.
  3. Don't wait until the last minute. Your cycles may become irregular again after stopping the medication, particularly if you regain weight. Some women regain ovulatory function that persists; others see PCOS symptoms return. Have a plan with your doctor for what to do if cycles become irregular again post-discontinuation.
  4. Consider at-home insemination as your first-line TTC strategy. Once you're cleared for conception, at-home insemination kits offer a private, affordable, and medically supported way to begin attempting conception without immediately escalating to expensive clinical procedures. MakeAmom's kits are FSA/HSA eligible and can be purchased with pre-tax dollars.

What If I Got Pregnant While Taking a GLP-1 Medication?

First: stop the medication immediately and contact your OB/GYN or midwife right away. Do not wait for your next scheduled appointment.

The risks associated with first-trimester GLP-1 exposure in humans are not yet well-characterized — the drug is too new and most exposure has been accidental. What we do know from animal data suggests risk, but animal-to-human translation is imperfect. Your provider will likely recommend early monitoring including an early viability ultrasound and possibly additional testing depending on your exposure window.

You should also report the exposure to the Novo Nordisk pregnancy registry (for semaglutide/liraglutide) or the Eli Lilly registry (for tirzepatide). These registries are how researchers build the human safety database for these medications during pregnancy. Your doctor can help you enroll.

GLP-1 Medications and Male Fertility

If your partner is male and taking a GLP-1 medication, there is emerging evidence worth discussing with their prescribing physician. Animal studies have shown effects on testicular tissue at high doses, and some case reports have described changes in sperm parameters in men on semaglutide. The human evidence is preliminary and far from conclusive, but if male-factor concerns are already on the table, it is worth raising this with your provider and potentially requesting a semen analysis.

Questions to Ask Your Doctor Before TTC on GLP-1 Medications

Before you start trying to conceive, make sure you've had these conversations with your healthcare provider:

The Bottom Line: GLP-1 Medications Are a Powerful Tool — With a Clear Stopping Point

For women with PCOS, obesity-related ovulatory dysfunction, or metabolic barriers to conception, GLP-1 medications can be a genuinely useful tool for preparing to get pregnant. They can restore ovulation, improve hormonal balance, and reduce the metabolic drivers of infertility. But they are not compatible with active attempts to conceive, and they are absolutely contraindicated during pregnancy itself.

The strategy is sequential: use GLP-1 therapy to optimize your reproductive baseline, then transition off the medication with a proper washout period, then begin trying to conceive. If you're working with donor sperm or inseminating at home, that window after stopping the medication and before the drug clears is also a good time to build your kit, learn your cycle, and track your ovulation so you're ready to act the moment you're cleared.

If you're navigating fertility with PCOS, our guides on berberine for PCOS and combining ICI with fertility medications have additional evidence-based strategies for your situation. And if you're ready to start the at-home insemination process, our kit finder quiz takes 30 seconds and recommends the right kit for your specific circumstances.

Ready to Start Your Journey?

Take our 30-second quiz to find the insemination kit designed for your specific situation.

Find Your Kit